← Back to Clinical Trials
Recruiting NCT01703429

NCT01703429 Complementary and Alternative Care in Multiple Sclerosis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT01703429
Status Recruiting
Phase
Sponsor Bastyr University
Condition Multiple Sclerosis
Study Type OBSERVATIONAL
Enrollment 1,000 participants
Start Date 2012-06
Primary Completion 2030-06

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 100 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,000 participants in total. It began in 2012-06 with a primary completion date of 2030-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This is a prospective, observational study designed to describe disease progression, symptom change, quality of life, diet and lifestyle habits, and frequency of adverse events among patients with multiple sclerosis (MS) who use complementary and alternative medicine (CAM). In addition to describing the patterns of CAM use, this study will also identify and describe the positive deviants, those individuals with the highest quality of life and least amount of disease activity. Positive deviants will be compared to controls in order to describe medication, diet, and lifestyle patterns associated with a lack of MS disease progression and high quality of life.

Eligibility Criteria

Inclusion Criteria: * Diagnosis of multiple sclerosis (including relapsing remitting MS, secondary progressive MS, primary progressive MS, clinically isolated syndromes (CIS), radiologically-isolated syndromes (RIS), possible MS, or probable MS. * Age 18-100 Exclusion Criteria: * Inability to read/write in English * Inability or unwillingness to complete surveys every six (6) months. (\~ 90 min)

Contact & Investigator

Central Contact

Research Assistant

✉ neuroresearch@bastyr.edu
Principal Investigator

Laurie K Mischley, ND, PhD, MPH

PRINCIPAL INVESTIGATOR

Bastyr University

Frequently Asked Questions

Who can join the NCT01703429 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Multiple Sclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT01703429 currently recruiting?

Yes, NCT01703429 is actively recruiting participants. Contact the research team at neuroresearch@bastyr.edu for enrollment information.

Where is the NCT01703429 trial being conducted?

This trial is being conducted at Kenmore, United States.

Who is sponsoring the NCT01703429 clinical trial?

NCT01703429 is sponsored by Bastyr University. The principal investigator is Laurie K Mischley, ND, PhD, MPH at Bastyr University. The trial plans to enroll 1,000 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology